by Ingrid Kroeze | Nov 4, 2024 | News
Today, at BNR Nieuwsradio, we spoke (in Dutch) about prevention and what OncoInv does to address the challenge of early detection of cancer. After all, prevention is and should be a key strategy to keep healthcare sustainable in the future. So how can we be better at...
by Ingrid Kroeze | Oct 7, 2024 | News
OncoInv and Healthcare Systems Mexico have joined forces to make multi cancer early detection available in Mexico. Healthcare Systems Mexico will be an exclusive distributor for OncoInv and will offer OncoSeek® as a novel means of detection of cancer in Mexico....
by Ingrid Kroeze | Apr 29, 2024 | News
Excellion (Nigeria) and OncoInv (The Netherlands) have joined forces to make multi cancer early detection available in Nigeria. OncoSeek® is a patient-friendly product to detect cancer as it is on a blood sample and requires no biopsy or imaging equipment. OncoSeek®...
by Ingrid Kroeze | Apr 12, 2024 | News
Two Sample Types, Three Different Platforms, Six Independent Cohorts of ~12,000 Cancer Patients and Non-cancer Individuals with Diverse Ethnic Backgrounds in Retrospective and Prospective Settings Validate OncoSeek’s Ability to Detect Multiple Cancer Types and...
by Ingrid Kroeze | Apr 10, 2024 | News
In Poland, cancers are detected in late stages, which makes effective treatment impossible. OnkoDiag places great emphasis on cancer prevention and that’s why they have chosen OncoSeek® for its offer. OncoSeek® is a patient-friendly product to detect cancer as...
by Ingrid Kroeze | Jan 9, 2024 | News
NM Genomix (Bulgaria) and OncoInv (the Netherlands) have joined forces to make multi cancer early detection available in Bulgaria. OncoSeek® is a patient-friendly product to detect cancer as it is on a blood sample and requires no biopsy or imaging equipment. Starting...
